Bandaram Pharma Packtech share price
BSE: 524602Healthcare ServicesSmall Cap
BANDARAM PHARMA PACKTECH LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1994
Last close ₹19.07up ₹1.13 (6.30%)
Share price at the BSE close on 27 Oct 2026. Previous close ₹17.94.
27 Oct: open ₹18.60, high ₹19.07, low ₹18.60
52-week range of traded prices to 27 Oct 2026
₹17.25Low, 20 Aug 2026₹49.70High, 2 Dec 2025
- Next results date: the board meets on 29 Oct 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹34 Cr3,419th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Owners' profit not stated
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.28
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.76
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,933
Results
Standalone, as consolidated accounts are on record for only 4 of the last ten years; ₹ crore.Bandaram Pharma Packtech quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +133.7%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- –
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹2.99 Crdown 63.58%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing. Net profit in the glossary
- −₹0.36 CrQuarter to Mar 2026: −₹0.33 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- −12.0%
Revenue by quarter
Peak revenue ₹8.20 Cr, quarter to Mar 2026; lowest ₹0.33 Cr, quarter to Sep 2025
Net profit by quarter, a loss in red
- Net profit
- Loss
A loss in 5 of the 8 quarters shown
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.17 | 2.63 | 3.71 | 0.76 | 0.33 | 1.68 | 8.20 | 2.99 |
| Net profit | 0.33 | 0.01 | 0.04 | −0.27 | −0.35 | −0.21 | −0.33 | −0.36 |
| Net margin | 10.4% | 0.6% | 1.2% | −35.5% | −105.5% | −12.6% | −4.0% | −12.0% |
Standalone. The last eight quarters. The latest is shaded.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹11 Crdown 10.37%
- Net profitNet profit. Under it, net profit in the year before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹1.16 CrYear to Mar 2025: ₹0.14 Cr
- Net margin
- −10.6%
Revenue by year
Peak revenue ₹15 Cr, year to Mar 2024; lowest ₹0.00 Cr, year to Mar 2022
Net profit by year, a loss in red
- Net profit
- Loss
A loss in the year to Mar 2026, −₹1.16 CrA loss in 4 of the 7 years with results on record
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | – | – | – | – | 0.0 | 10.1 | 14.8 | 12.2 | 11.0 |
| Net profit | −1.1 | −1.2 | – | – | – | 0.0 | 0.2 | 0.1 | 0.1 | −1.2 |
| Net margin | −3,633.3% | – | – | – | – | – | 2.0% | 0.9% | 1.1% | −10.6% |
Standalone. Years to March. The latest is shaded. No results on record for the years to Mar 2019, Mar 2020 and Mar 2021.
Business segments
In the year to Mar 2026 the company reports one business segment, Paper and Packaging, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, P/E: a quarter's profit for shareholders does not agree with its own earnings per share.Bandaram Pharma Packtech PE ratio and valuation
Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.
At or below today's level on 4% of 663 trading days over the last 3 years.
LowestHighest
Its median0.30%Industry median0.36%
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −49.3% | – | – | 0.0% |
Longer windows are left empty: a corporate action or price step on 2023-07-03 that cannot be sized sits inside this window. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1 year is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Promoter and insider buying and selling
Trades made since 28 Oct 2025.Bandaram Pharma Packtech insider trading
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade · 4 off-market moves
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Bandaram Pharma Packtech competitors and peers
Healthcare Service Provider, 36 listed companies, priced on 27 Oct 2026. The table lists the 8 companies closest to Bandaram Pharma Packtech in market cap.Healthcare companies
Bandaram Pharma Packtech is not on the chart: it has no P/E or return on equity today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Star Imaging and Path LabSTARIMAGIN | 131 | 6.78 | 1.13 | – | – | 16.6% | – | 0.00% |
 Aspira Pathlab & DiagnosticsASPIRA | 129 | – | 10.52 | +14.6% | −117.7% | −3.7% | −4.4% | 0.00% |
 Modern Diagnostic & Research CentreMDRC | 92 | 17.53 | 1.57 | – | – | 9.0% | – | 0.00% |
 Invicta DiagnosticINVICTA | 84 | 17.04 | 1.67 | – | – | 9.8% | 12.2% | 0.00% |
 N.G.IndustriesNGIND | 34 | 17.49 | 1.00 | +2.2% | −74.1% | 5.3% | 3.7% | 3.48% |
 Deccan Health CareDECCAN | 29 | 11.61 | 0.27 | −0.4% | +145.9% | 2.3% | 3.3% | 0.00% |
 Samsrita LabsSAMSRITA | 28 | – | 2.34 | – | – | – | −65.3% | 0.00% |
 Sharma East India Hospitals and ResSHARMEH | 26 | 22.30 | 1.93 | +14.1% | −9.9% | 9.0% | 9.1% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Bandaram Pharma Packtech dividend history
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up. Dividend per share in the glossaryHighest ₹0.10 a share, years to Mar 2023, Mar 2024 and Mar 2025.
| Ex-date | Type | Per share |
|---|---|---|
| 22 Sep 2025 | Final | ₹0.10 |
| 20 Sep 2024 | Final | ₹0.10 |
| 22 Sep 2023 | Final | ₹0.10 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Bandaram Pharma Packtech announcements
Oct 2026
23 Oct · Board meeting
Meeting on 29 Oct 2026: quarterly results
Sep 2026
30 Sep · Board meeting
28 Sep · Board meeting
Meeting on 30 Sep 2026: amalgamation and scheme of arrangement24 Sep · Meeting
Bandaram Pharma Packtech share price by year
Each calendar year to 2025.Bandaram Pharma Packtech share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 29.77 | −34.8% | 50.00 | 23.33 |
| 2024 | 45.67 | +48.8% | 60.14 | 28.81 |
| 2023 | 30.69 | – | 30.69 | 25.26 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2023 is from its first session, 3 Jul 2023. The 2023 close is its last trade, on 18 Dec 2023.
Recent sessions
The 9 trading days to 26 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 26 Oct 2026 | 18.31 | 19.05 | 17.90 | 17.94 | 18.71 | 2,669 |
| 23 Oct 2026 | 19.35 | 19.35 | 17.25 | 18.21 | 18.05 | 930 |
| 22 Oct 2026 | 19.60 | 19.60 | 19.00 | 19.00 | – | 68 |
| 21 Oct 2026 | 19.07 | 19.59 | 18.36 | 19.24 | 19.24 | 177 |
| 19 Oct 2026 | 19.05 | 19.05 | 19.05 | 19.05 | 19.05 | 1 |
| 16 Oct 2026 | 18.61 | 19.47 | 18.60 | 18.60 | 18.60 | 12,198 |
| 15 Oct 2026 | 19.50 | 19.50 | 18.52 | 18.52 | 19.48 | 5,402 |
| 14 Oct 2026 | 18.50 | 19.10 | 17.75 | 19.10 | 18.46 | 276 |
| 13 Oct 2026 | 18.60 | 18.60 | 17.85 | 18.55 | 18.27 | 451 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Rights issue and open offer history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 3 Jul 2023 | Price move | – | A corporate action went ex within three days of this move (Right Issue of Equity Shares, ex-date 30 Jun 2023), and its terms do not account for the move. Earlier prices are not shown. |
| 30 Jun 2023 | Rights issue | – | Shareholders were offered new shares. Noted, not adjusted for. |
| 18 Nov 2022 | Price move | – | This is the share's first trade after a corporate action (Resolution Plan -Suspension, ex-date 16 Mar 2022), and the action's terms do not account for the move. Not adjusted for. |
| 27 May 2016 | Price move | – | This is the share's first trade after a corporate action (Reduction of Capital, ex-date 3 Dec 2015), and the action's terms do not account for the move. Earlier prices are not shown. |
Where an event has no factor that can be worked out, the chart leaves out the closes before it. Any other event is noted and not adjusted for.
Company details
- BSE code
- 524602
- ISIN
- INE875N01036
- Industry
- Healthcare Services
- Website
- www.bandaram.com
- CIN
- L93090KA1993PLC159827
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1993
- Registered office
- 601, 5th Floor, Oxford Towers, Opp to Leela Palace Hotel, Old Airport Road, Kodihalli, Bengaluru 560008, Karnataka
- Share registrar
- Cameo Corporate Services Ltd
- Keeps the register of shareholders and handles transfers and dividend payments